Record Display for the EPA National Library Catalog


Main Title Validation of an Estrogen Receptor Binding Assay using Rat Uterine Cytosol as Source of Receptor as a Potential Screen in the Endocrine Disruptor Screening Program Tier 1 Battery. Integrated Summary Report.
CORP Author Environmental Protection Agency, Washington, DC. Office of Research and Development.
Year Published 2009
Stock Number PB2010-104723
Additional Subjects Test methods ; Binding assays ; Endocrine disrupters ; Estrogen receptors ; Assaying ; Detection ; Public health ; Procedures ; Evaluation ; Screening ; Validation ; Protocols ; Testing ; Endocrine Disruptor Screening Program(EDSP)
Library Call Number Additional Info Location Last
NTIS  PB2010-104723 Some EPA libraries have a fiche copy filed under the call number shown. 07/26/2022
Collation 94p
Purpose of the Endocrine Disruptor Screening Program Section 408(p) of the Federal Food Drug and Cosmetic Act (FFDCA) requires the U.S. Environmental Protection Agency (EPA) to develop a screening program, using appropriate validated test systems and other scientifically relevant information, to determine whether certain substances may have an effect in humans that is similar to an effect produced by a naturally occurring estrogen, or other such endocrine effect as the Administrator may designate (21 U.S.C. 346a(p)). Subsequent to passage of the Act, the EPA formed the Endocrine Disruptor Screening and Testing Advisory Committee (EDSTAC), a committee of scientists and stakeholders that was charged by the EPA to provide recommendations on how to implement its Endocrine Disruptor Screening Program (EDSP).